Andrew D. Miller

9.3k total citations · 1 hit paper
195 papers, 6.9k citations indexed

About

Andrew D. Miller is a scholar working on Molecular Biology, Genetics and Materials Chemistry. According to data from OpenAlex, Andrew D. Miller has authored 195 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 141 papers in Molecular Biology, 48 papers in Genetics and 24 papers in Materials Chemistry. Recurrent topics in Andrew D. Miller's work include RNA Interference and Gene Delivery (72 papers), Advanced biosensing and bioanalysis techniques (50 papers) and Virus-based gene therapy research (32 papers). Andrew D. Miller is often cited by papers focused on RNA Interference and Gene Delivery (72 papers), Advanced biosensing and bioanalysis techniques (50 papers) and Virus-based gene therapy research (32 papers). Andrew D. Miller collaborates with scholars based in United Kingdom, United States and Czechia. Andrew D. Miller's co-authors include Michael Keller, Nazila Kamaly, Charles Coutelle, Jimmy D. Bell, Michael R. Jorgensen, Richard P. Harbottle, Maya Thanou, Kostas Kostarelos, Stephen L. Hart and Monika Preuss and has published in prestigious journals such as Chemical Society Reviews, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Andrew D. Miller

193 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines

2019 275 citations Daniel Růžek, Tatjana Avšič‐Županc et al. Antiviral Research profile →

Peers

Countries citing papers authored by Andrew D. Miller

Since Specialization

Citations

This map shows the geographic impact of Andrew D. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Miller more than expected).

Fields of papers citing papers by Andrew D. Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Miller. The network helps show where Andrew D. Miller may publish in the future.

Co-authorship network of co-authors of Andrew D. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. Miller. A scholar is included among the top collaborators of Andrew D. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. Miller. Andrew D. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diphyllin Shows a Broad-Spectrum Antiviral Activity against Multiple Medically Important Enveloped RNA and DNA Viruses 2022 ·Viruses ·Michal Štefánik, (unknown), Jan Haviernik, Petra Straková, Martina Fojtíková, Lucie Dufková, (unknown), Jiřı́ Salát, (unknown), Jan Svoboda, Miloš Sedlák, Daniel Růžek, Andrew D. Miller, Luděk Eyer	19
2	Selected ginsenosides interfere efficiently with hepatitis B virus mRNA expression levels and suppress viral surface antigen secretion 2022 ·Heliyon ·G Duraisamy, Eunji Jo, (unknown), Kyu‐Ho Park, Zbyněk Heger, Vojtěch Adam, Daniel Růžek, Marc P. Windisch, Andrew D. Miller	5
3	Antiviral Activity of Vacuolar ATPase Blocker Diphyllin against SARS-CoV-2 2021 ·Microorganisms ·Michal Štefánik, Petra Straková, Jan Haviernik, Andrew D. Miller, Daniel Růžek, Luděk Eyer	22
4	Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines breakdown → 2019 ·Antiviral Research ·Daniel Růžek, Tatjana Avšič‐Županc, J Borde, Aleš Chrdle, Luděk Eyer, Galina G. Karganova, Ivan S. Kholodilov, Nataša Knap, Liubov I. Kozlovskaya, Andrey L. Matveev, Andrew D. Miller, Dmitry I. Osolodkin, Anna K. Överby, Nina V. Tikunova, Sergey Tkachev, Joanna Zajkowska	275
5	Cationic lipid-based nanoparticles mediate functional delivery of acetate to tumor cells in vivo leading to significant anticancer effects 2017 ·International Journal of Nanomedicine ·Leigh Brody, Meliz Sahuri-Arisoylu, James R.C. Parkinson, Harold G. Parkes, Po‐Wah So, Nabil Hajji, E. Louise Thomas, Gary Frost, Andrew D. Miller, Jimmy D. Bell	16
6	Direct Intracranial Injection of AAVrh8 Encoding Monkey β-N-Acetylhexosaminidase Causes Neurotoxicity in the Primate Brain 2017 ·Human Gene Therapy ·Diane Golebiowski, I.M.J. van der Bom, Churl‐Su Kwon, Andrew D. Miller, (unknown), Allison M. Bradbury, Stacy A. Maitland, Anna Luisa Kühn, (unknown), Elizabeth Curran, (unknown), (unknown), Susan V. Westmoreland, Douglas R. Martin, Matthew J. Gounis, Wael F. Asaad, Miguel Sena‐Esteves	66
7	Effect of surface charge and ligand organization on the specific cell-uptake of uPAR-targeted nanoparticles 2013 ·Journal of drug targeting ·Ming Wang, Andrew D. Miller, Maya Thanou	13
8	Assessing the preferred solution conformation of an interacting sense–antisense (complementary) peptide pair 2012 ·Bioorganic & Medicinal Chemistry Letters ·James Pullen, (unknown), Stefano A. Serapian, Andrew D. Miller	4
9	Efficient topical delivery of plasmid DNA to lung in vivo mediated by putative triggered, PEGylated pDNA nanoparticles 2011 ·Journal of Controlled Release ·Abderrahim Aissaoui, Mohamed Chami, (unknown), Andrew D. Miller	25
10	Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector 2008 ·Gene Therapy ·Orestis Argyros, Suet Ping Wong, Marcello Niceta, Simon N. Waddington, Steven J. Howe, Charles Coutelle, Andrew D. Miller, Richard P. Harbottle	73
11	Quantitative real-time PCR study on persistence of pDNA vaccine pVax-Hsp60 TM814 in beef muscles 2008 ·PubMed ·(unknown), (unknown), Milan Raška, Andrew D. Miller, M Ledvina, Jaroslav Tuřánek	8
12	A novel method of continuous measurement of head of bed elevation in ventilated patients 2007 ·Intensive Care Medicine ·Konstantin Balonov, Andrew D. Miller, Alan Lisbon, A. Murat Kaynar	15
13	The duality of LysU, a catalyst for both Ap₄A and Ap₃A formation 2006 ·FEBS Journal ·Michael Wright, (unknown), Julian A. Tanner, Alison D. Hindley, Andrew D. Miller	22
14	Synthetic, self-assembly ABCD nanoparticles; a structural paradigm for viable synthetic non-viral vectors 2005 ·Chemical Society Reviews ·Kostas Kostarelos, Andrew D. Miller	141
15	Site-directed genome modification: derivatives of DNA-modifying enzymes as targeting tools 2005 ·Trends in biotechnology ·Craig J. Coates, Joseph Kaminski, James B. Summers, David J. Segal, Andrew D. Miller, Andreas F. Kolb	33
16	Nonviral Liposomes 2004 ·Humana Press eBooks ·Andrew D. Miller	2
17	Nuclear Localisation Sequence Templated Nonviral Gene Delivery Vectors: Investigation of Intracellular Trafficking Events of LMD and LD Vector Systems 2003 ·ChemBioChem ·Michael Keller, Richard P. Harbottle, Éric Pérouzel, Morvane Colin, Syed Imran Ali Shah, Rahimin Affandi Abdul Rahim, Laurence Vaysse, (unknown), S. Moritz, Christiane Brahimi‐Horn, Charles Coutelle, Andrew D. Miller	59
18	Specific Interactions Between Sense and Complementary Peptides: The Basis for the Proteomic Code 2002 ·ChemBioChem ·Jonathan R. Heal, Gareth W. Roberts, John G. Raynes, (unknown), Andrew D. Miller	56
19	Access to the inaccessible sequence of Cpn 60.1 (195–217) by temporary oxazolidine protection of selected amide bonds 2001 ·Bioorganic & Medicinal Chemistry Letters ·Michael Keller, Andrew D. Miller	13
20	The crystal structure of the lysyl-tRNA synthetase (LysU) from Escherichia coli 1995 ·Structure ·Silvia Onesti, Andrew D. Miller, P. Brick	108

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact